Reed Vaughn Tuckson Henry Schein Inc (HSIC) insider trading activity

Reed Vaughn Tuckson is of HENRY SCHEIN INC. Currently has a direct ownership of 9,943 shares of HSIC, which is worth approximately $717,884. The most recent transaction as insider was on Jun 11, 2025, when has been sold 487 shares (Common Stock, par value $0.01 per share) at a price of $71.14 per share, resulting in proceeds of $34,645. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.94K

31.07% 3M change

21.88% 12M change

Total Value Held $717,884

Reed Vaughn Tuckson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 11 2025	SELL Payment of exercise price or tax liability	$34,645 $71.14 p/Share	487 Reduced 4.67%	9,943 Common Stock, par valu...
Mar 04 2025	SELL Payment of exercise price or tax liability	$40,217 $70.31 p/Share	572 Reduced 7.01%	7,586 Common Stock, par valu...
Mar 04 2025	BUY Grant, award, or other acquisition	-	2,844 Added 21.43%	10,430 Common Stock, par valu...
Mar 04 2024	BUY Grant, award, or other acquisition	-	2,604 Added 24.2%	8,158 Common Stock, par valu...
Mar 01 2024	SELL Payment of exercise price or tax liability	$38,055 $76.88 p/Share	495 Reduced 8.18%	5,554 Common Stock, par valu...
Mar 16 2023	SELL Payment of exercise price or tax liability	$34,854 $78.15 p/Share	446 Reduced 6.87%	6,049 Common Stock, par valu...
Mar 01 2023	BUY Grant, award, or other acquisition	-	2,250 Added 25.73%	6,495 Common Stock, par valu...
Mar 16 2022	BUY Grant, award, or other acquisition	-	2,028 Added 32.33%	4,245 Common Stock, par valu...
Jun 11 2021	BUY Grant, award, or other acquisition	-	2,217 Added 50.0%	2,217 Common Stock, par valu...

Also insider at

ADVM

Adverum Biotechnologies, Inc. Healthcare

CTIC

CTI BIOPHARMA CORP Healthcare

Director

RVT